CURRICULUM VITAE

PERSONAL DETAIL

PROF. DR. AHMAD HATIM BIN SULAIMAN

Department of Psychological Medicine
Faculty of Medicine
 
  +603-79402068
  +603-79571058
  hatim@um.edu.my
 Department of Psychological Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia
 
ResearcherID Link
   http://www.researcherid.com/rid/B-8156-2010


BIBLIOMETRIC DATA

 Total Articles in Publication List  66
 Articles With Citation Data  66
 Sum of the Times Cited   465
 Average Citations per Article   7.05
 h-index   13
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

ACADEMIC QUALIFICATION
(Qualification), (Institution).


PROFESSIONAL
(Organisation), (Role), (Year), (Level).

  • Malaysian Journal of Psychiatry, Reviewer, 2002, (National)
  • MALAYSIAN PSYCHIATRIC ASSCOCIATION, Secretary, 2004, (National)
  • WORLD PSYCHIATRIC ASSOCIATION, Young Psychiatrist Council Member, 2005, (International)
  • MALAYSIAN PSYCHIATRIC ASSCOCIATION, Treasurer, 2006 to 2008, (National)
  • International Early Psychosis Association, Membership, 2006, (International)
  • NATIONAL SPECIALIST REGISTER (SPECIALTY SUB-COMMITTEE: PSYCHIATRY), Chairman, 2009 to 2012, (National)
  • Malaysian Psychiatric Association, Editorial Board Member, 2009, (National)
  • International Society of Bipolar Disorder, Membership, 2010 to 2011, (International)
  • International Journal of Clinical Practice, Reviewer, 2011 to 2011, (International)
  • Quest International University, Expert Panel Member, 2012 to 2012, (National)
  • Current Drug Treatment: Guest Editor for special issue "Advances in Psychopharmacological Treatment" , Editorial Member, 2016 to 2018, (International)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).

  • Head of Department, Psychological Medicine, Faculty of Medicine, 01/10/2018 to 30/09/2020
  • Head of Department, Psychological Medicine, Faculty of Medicine, 01/08/2014 to 31/07/2016
  • Head of Department, Psychological Medicine, Faculty of Medicine, 01/07/2014 to 31/07/2014
  • Head of Department, Psychological Medicine, Faculty of Medicine, 01/09/2012 to 30/06/2014
  • Head of Department, Psychological Medicine, Faculty of Medicine, 01/07/2012 to 31/08/2012
  • Head of Department, Psychological Medicine, Faculty of Medicine, 09/07/2011 to 30/06/2012
  • Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya, 08/08/2011 to 15/08/2014
  • Ahli Majlis Penasihat Perubatan, Pusat Perubatan Universti Malaya, University Malaya, 30/07/2011 to 30/06/2014
  • Pengerusi, Jawatankuasa Latihan Bersama Ijazah Sarjana Psikiatri, National, 10/07/2011 to 31/12/2012 (Pengerusi Jawatankuasa Bersama Ijazah Sarjana Psikiatri)
  • Chairman for Exam Question Vetting Committee (Dept of Psychological Medicine), Faculty, 09/07/2011 to 30/06/2014
  • Penyelaras Program Sarjana Perubatan Psikologi, Faculty, 09/07/2011 to 30/06/2014
  • Ahli Jawatankuasa Ubat-ubatan dan Therapeutik, Pusat Perubatan Universiti Malaya, University Malaya, 09/07/2011 to 30/06/2014
  • Ahli Jawatankuasa Etika Perubatan, Pusat Perubatan Universiti Malaya, University Malaya, 09/07/2011 to 09/10/2014
  • Internal Examiner for Post Graduate Exam, Master in Psychological Medicine, National, 03/12/2007
  • Internal Examiner for MBBS Final Exam, Faculty, 01/06/2001
  • Penyelaras Unit Kajian Psikopharmakologi, Jabatan Perubatan Psikologi, Faculty, 01/06/2001 to 30/06/2014

AREAS OF EXPERTISE
(Area).

  • Psychiatry (Psychopharmacology)


RECENT SELECTED PUBLICATIONS
(Publication).

Book

2011
  • M.H.Habil, R.Abdul Rashid & S.A.Jazaeri.2011.Perspectives of Addiction Medicine in Malaysia. 

2006
  • Hussain Habil, Ahmad Hatim. Kemurungan: Punca dan rawatan. University Malaya Press. 2006 (Non-ISI/Non-SCOPUS)

2005
  • National Methadone Maintenance Therapy Guideline. Ministry of Health Malaysia May 2005. 
Article in Academic Journals

2020
  • Nakao Iwata, Jun Ishigooka, Won-Hyoung Kim, Bo-Hyun Yoon, Shih-Ku Lin, Ahmad Hatim Sulaiman, Rowena Cosca, Lina Wang, Yury Suchkov, Alexey Agarkov, Kei Watabe, Tomohito Matsui,Takayuki Sato, Yoshifumi Inoue, Teruhiko Higuchi, Christoph U. Correll, John M. Kan.(2020). Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study. Schizophrenia Research 215(2020):408 - 415 (ISI-Indexed)

2019
  • Zuraida, A.S., Che Zarrina, S., Sharifah Basirah, S.M., Goh, L.K., Sulaiman, A.H., Koenig, H.G. (2019). Islamic Integrated Cognitive Behavior Therapy: A Shari'ah-Compliant Intervention for Muslims with Depression. Malaysian Journal of Psychiatry. 28 (1). (SCOPUS-Indexed)
  • Yan Sun, Gang Chen, Li Wang, Nan Li, Manit Srisurapanont, Jin Pyo Hong, Ahmad Hatim, Chia-hui Chen, Pichet Udomratn, Jae Nam Bae , Yi-Ru Fang, Hong Choon Chua, Shen-Ing Liu, Tom George, Dianne Bautista, Edwin Chan, A. John Rush, Hong Yang, Yun-Ai Su and Tian-Mei Si, on behalf of the Mood Disorders Research: Asian & Australian Network Perception of Stigma and Its Associated Factors Among Patients with Major Depressive Disorder: A Multicenter Survey from an Asian Population. Frontiers in Psychiatry: May 2019 | Volume 10 | Article 321 (ISI-Indexed)
  • Michael Bauera,Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos, Raffaella Ardau, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard T. Baune, Claudia Becerra-Palars, Frank Bellivier, Robert H. Belmaker, Michael Berk, Yuly Bersudsky, Şule Bicakci, Harriet Birabwa-Oketcho, Thomas D. Bjella, Jorge Cabrera, Eric Y. Wo Cheung,Maria Del Zompo, Seetal Dodd, Markus Donix, Bruno Etain, Andrea Fagiolini, Kostas N. Fountoulakis, Mark A. Frye, Ana Gonzalez-Pinto, John F. Gottlieb, Paul Grof, Hirohiko Harima, Chantal Henry, Erkki T. Isometsä, Sven Janno, Flávio Kapczinski, Mathias Kardell, Slim Khaldi, Sebastian Kliwicki, Barbara König, Timur L. Kot, Rikke Krogh, Mauricio Kunz, Beny Lafer, Mikael Landén, Erik R. Larsen, Ute Lewitzk, Rasmus W. Lichtao, Carlos Lopez-Jaramillo, Glenda MacQueen,Mirko Manchia, Wendy Marsh, Mónica Martinez-Cengotitabengo, Ingrid Melle, Fátima Meza-Urzú, Mok Yee Ming, Scott Monteith, Gunnar Gorken, Enrica Mosc, Anton A. Mozzhegorov, Rodrigo Munoz, Starlin V. Mythria, Fethi Nacef,Ravi K. Nadella, Fabiano G. Nery, René E. Nielsen, Claire O'Donovan, Adel Omrania,Yamima Osher, Helle Østermark Sørensen, Uta Oualia, Yolanda Pica Ruiza, Maximilian Pilhatsch, Marco Pinna, Francisco D.R. da Ponte, Danilo Quiroza,Raj Ramesara, Natalie Rasgona, M.S. Reddy, Andreas Reifa, Philipp Ritter, Janusz K. Rybakowski, Kemal Sagduyu, Bharathram Sathur Raghuraman,Ângela M. Scippa, Emanuel Severus, Christian Simhandl, Paul W. Stackhouse Jr.,Dan J. Stein, Sergio Strejilevich, Mythily Subramaniam, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagat, Yoshitaka Tatebayashi, Leonardo Tondo,Carla Torrent, Arne E. Vaaler, Edgar Vares, Julia Veeh, Eduard Vieta,Biju Viswanath, Maria Yoldi-Negrete, Mark Zetin, Yosra Zgueb, Peter C. Whybrow. Association between solar insolation and a history of suicide attempts in bipolar I disorder. Journal of Psychiatric Research 113 (2019) 1–9 (ISI-Indexed)
  • Rusdi Abd Rashid, Sharmilla Kanagasundram, Mahmoud Danaee, Hazreen Abdul Majid , Ahmad Hatim Sulaiman, Muhammad Muhsin Ahmad Zahari, Chong Guan Ng, Benedict Franci , Wan Azlinda IrneeWan Husin and Tin Tin Su. The Prevalence of Smoking, Determinants and Chance of Psychological Problems among Smokers in an Urban Community Housing Project in Malaysia .Int. J. Environ. Res. Public Health 2019, 16, 1762; doi:10.3390/ijerph16101762 (ISI-Indexed)
  • Benedict Francis,Jesjeet Singh Gill , Ng Yit Han, Chiara Francine Petrus ,Fatin Liyana Azhar , Zuraida Ahmad Sabki ,Mas Ayu Said, Koh Ong Hui ,Ng Chong Guan and Ahmad Hatim Sulaiman. Religious Coping, Religiosity, Depression and Anxiety among Medical Students in a Multi-Religious Setting. Int. J. Environ. Res. Public Health 2019, 16(259); doi:10.3390/ijerph16020259 (ISI-Indexed)

2018
  • Syahrir Zaini, NG Chong Guan , Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Hasniza Zaman Huri, Siti Hadijah Shamsudin. The Use of Antidepressants for Physical and Psychological Symptoms in Cancer. Current Drug Target 2018 Feb 26. doi: 10.2174/1389450119666180226125026. [Epub ahead of print] (ISI-Indexed)
  • Emsley R, Ahokas A, Suarez A, Marinescu D, Dóci I, Lehtmets A, Milanova V, Lee MS, Didi R, Araszkiewicz A, Sulaiman AH, Blanchot FP, Crutel VS, Antoine C, Penelaud PF. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study. (ISI-Indexed)
  • Syahrir Zaini , Harvin Anbu Manivanna Bharathy , Ahmad Hatim Sulaiman , Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan. Development of a Strategic Tool for Shared Decision-Making in the Use of Antidepressants among Patients with Major Depressive Disorder: A Focus Group Study. Int. J. Environ. Res. Public Health 2018, 15, 1402; doi:10.3390/ijerph15071402 (ISI-Indexed)
  • Anne Yee, Huai Seng Loh , Teng Aik Ong, Chong Guan Ng,Ahmad Hatim Sulaiman. Randomized, Double-Blind, Parallel- Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. American Journal of Men’s Health. DOI: 10.1177/1557988318784152. journals.sagepub.com/home/jmh (ISI-Indexed)
  • Anne Yee, Huai Seng Loh, Mahmoud Danaee, Shahrzad Riahi, Chong Guan Ng, and Ahmad Hatim Sulaiman. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment. Journal of Sexual Medicine 2018. https://doi.org/10.1016/j.jsxm.2017.12.004 (ISI-Indexed)
  • Gill JS, Sulaiman AH. QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report. Turk Psikiyatri Derg. 2018 ;29(1):67-68. (ISI-Indexed)
  • Ahmad Hatim Sulaiman, Ramli Musa. Editorial: Advances in Psychopharmacological Treatment. Current Drug Target (2018).19(8): 855 (ISI-Indexed)
  • Ramli Musa and Ahmad Hatim Sulaiman. The Therapeutic and Psychosocial Interaction in Enhancing Drug Targets. Current Drug Target (2018) 19(12): 1351 (ISI-Indexed)

2017
  • Tahereh Seghatoleslam, Hussain Habil, Ahmad Hatim, Abolfazl Ardakani, Khafidz Ishak, Rusdi Rashid. Evaluation of Psychometric Properties of the Second Version of the Taqwa (Piety) Questionnaire in Bahasa Melayu. J Relig Health. DOI 10.1007/s10943-017-0362-8 (ISI-Indexed)
  • Guan Chong Ng, Salina Mohamed, Ahmad Hatim Sulaiman, Nor Zuraida Zainal. Anxiety and Depression in Cancer Patients: The Association with Religiosity and Religious Coping. J Relig Health (2017) 56:575-590. (ISI-Indexed)
  • Narong Maneeton, Sirijit Suttajit, Benchalak Maneeton, Surinporn Likhitsathian , Kanokkwan Eurviyanukul, Pichet Udomratn, Edwin Shih-Yen Chan, Tian-Mei Si, Ahmad Hatim Sulaiman, Chia-Hui Chen, Dianne Bautista, Manit Srisurapanont. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder. Nordic Journal of Psychiatry July 2017. DOI: 10.1080/08039488.2017.1335344 (ISI-Indexed)
  • Joni Bing Fei Teoh, Anne Yee, Mahmoud Danaee, Chong Guan Ng, Ahmad Hatim Sulaiman. Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life. Journal of Addiction Medicine 2017. 11: 40-46. (ISI-Indexed)
  • Ng Chong Guan, PhD1, Salina Mohamed, MPM2, Kiran Kaur MD 3 Ahmad Hatim Sulaiman, PhD1, Nor Zuraida Zainal, MPhil1, Nur Aishah Taib, MD3 , MyBCC Study group. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One.12(3):e0172975. doi: 10.1371/journal.pone.0172975. (ISI-Indexed)

2016
  • Chong Guan Ng, Kiah Tian Lai, Seng Beng Tan, Ahmad Hatim Sulaiman, Nor Zuraida Zainal (2016). The Effect of 5 Minutes of Mindful Breathing to the Perception of Distress and Physiological Responses in Palliative Care Cancer Patients: A Randomized Controlled Study. Journal of Palliative Medicine. DOI: 10.1089/jpm.2016.0046 (ISI-Indexed)
  • Rita Bauer, Jörn Conell, Tasha Glenn, Martin Alda, Raffaella Ardau, Bernhard T. Baune, Michael Berk, Yuly Bersudsky, Amy Bilderbeck, Alberto Bocchetta, Letizia Bossini, Angela M. Paredes Castro, Eric YW. Cheung,Caterina Chillotti, Sabine Choppin, Maria Del Zompo, Rodrigo Dias, Seetal Dodd, Anne Duffy, Bruno Etain, Andrea Fagiolini, Miryam Fernández Hernandez, Julie Garnham, John Geddes, Jonas Gildebro, Ana Gonzalez-Pinto, Guy M. Goodwin, Paul Grof, Hirohiko Harima, Stefanie Hassel, Chantal Henry, Diego Hidalgo-Mazzei, Vaisnvy Kapur, Girish Kunigiri, Beny Lafer, Erik R. Larsen, Ute Lewitzka, Rasmus W. Licht, Anne Hvenegaard Lund, Blazej Misiak, Scott Monteith, Rodrigo Munoz, Takako Nakanotani, René E Nielsen, Claire O’Donovan, Yasushi Okamura, Yamima Osher, Patryk Piotrowski, Andreas Reif, Philipp Ritter, Janusz K. Rybakowski, Kemal Sagduyu, Brett Sawchuk, Elon Schwartz, Ângela M. Scippa, Claire Slaney, Ahmad H. Sulaiman, Kirsi Suominen, Aleksandra Suwalska, Peter Tamar, Yoshitaka Tatebayashi, Leonardo Tondo, Eduard Vieta, Maj Vinberg, Biju Viswanath, Julia Volkert, Mark Zetin, Peter C. Whybrowax, Michael Bauer. (2016) Internet use by patients with bipolar disorder: Results from an international multi-site survey. Psychiatry Research, 242:388-394. (ISI-Indexed)
  • NA Hashim, S Ariaratnam, MR Salleh, MA Said, AH Sulaiman. Depression and associated factors in Patients with Type 2 Diabetes Mellitus. East Asian Archives of Psychiatry. 26(2):77-82 (Non-ISI/Non-SCOPUS)
  • Ng CG, Lai KT, Tan SB, Sulaiman AH, Zainal NZ. (2016) The Effect of Five Minutes Mindful Breathing to the Perception of Distress and Physiological Responses in Palliative Care Cancer Patients: A Randomized Controlled Study. Journal of Palliative Medicine. 19(9): 917-924 (ISI-Indexed)
  • Anne Yee, Mahmoud Danaee, Huai Seng Loh, Ahmad Hatim Sulaiman, Chong Guan Ng. Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment.PLoS One.Jan 2016. DOI:10.1371/journal.pone.0147852 (ISI-Indexed)
  • Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon, David Castle. Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region. Asia-Pacific Psychiatry.2016 (ISI-Indexed)

2015
  • Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: a 1-year prospective study. Chong Guan Ng1*, Salina Mohamed2, Mee Hoong See3, Faizah Harun3, Maznah Dahlui4, Ahmad Hatim Sulaiman1, Nor Zuraida Zainal1, Nur Aishah Taib3 and on behalf of the MyBCC Study group (ISI-Indexed)
  • Chong Guan Ng, Salina Mohamed, Mee Hoong See, Faizah Harun, Maznah Dahlui, Ahmad Hatim Sulaiman,Nor Zuraida Zainal, Nur Aishah Taib and on behalf of the MyBCC Study group. 2015. Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: A 1-year prospective study. Health and Quality of Life Outcomes 13(1): 205 (Open Access) (ISI-Indexed)
  • Liu YH, Chen L, Su YA, Fang YR, Srisurapanont M, Hong JP, Hatim A, Chua HC, Bautista D, Si TM. Is Early-onset in Major Depression a Predictor of Specific Clinical Features with More Impaired Social Function?. Chin Med J 2015;128:811-5. (ISI-Indexed)
  • M. Bauer, T. Glenn, M. Alda, O.A. Andreassen, E. Angelopoulos, R. Ardau, C. Baethge, R. Bauer, F. Bellivier, R.H. Belmaker, M. Berk, T.D. Bjella, L. Bossini, Y. Bersudsky, E.Y.W. Cheung, J. Conell, M. Del Zompo, S. Dodd, B. Etain, A. Fagiolini, M.A. Frye, K.N. Fountoulakis, J. Garneau-Fournier, A. Gonzalez-Pinto, H. Harima, S. Hassel, C. Henry, A. Iacovides, E.T. Isomets�F. Kapczinski, S. Kliwicki, B. K�nig, R. Krogh, M. Kunz, B. Lafer, E.R. Larsen, U. Lewitzka, C. Lopez-Jaramillo, G. MacQueen, M. Manchia, W. Marsh, M. Martinez- Cengotitabengoa, I. Melle, S. Monteith, G. Morken, R. Munoz, F.G. Nery, C. O�Donovan, Y. Osher, A. Pfennig, D. Quiroz, R. Ramesar, N. Rasgon, A. Reif, P. Ritter, J.K. Rybakowski, K. Sagduyu, A.M. Scippa, E. Severus, C. Simhandl, D.J. Stein, S. Strejilevich, A. Hatim Sulaiman, K. Suominen, H. Tagata, Y. Tatebayashi, C. Torrent, E. Vieta, B. Viswanath, M.J. Wanchoo, M. Zetin, P.C. Whybrow. 2015. Influence of birth cohort on age of onset cluster analysis in Bipolar I Disorder. European Psychiatry 30(1): 99-105 (ISI-Indexed)
  • Michael Bauer, Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos , Raffaella Ardau, Christopher Baethge, Rita Bauer, Frank Bellivier, Robert H Belmaker, Michael Berk, Thomas D Bjella, Letizia Bossini, Yuly Bersudsky, Eric Yat Wo Cheung, J rn Conell, Maria Del Zompo, Seetal Dodd, Bruno Etain, Andrea Fagiolini, Mark A. Frye, Kostas N Fountoulakis, Jade Garneau-Fournier, Ana Gonzalez- Pinto, John F. Gottlieb, Hirohiko Harima, Stefanie Hassel, Chantal Henry, Apostolos Iacovides, Erkki T Isomets Fl o Kapczinski, Sebastian Kliwicki, Barbara K nig, Rikke Krogh, Mauricio Kunz, Beny Lafer, Erik R Larsen, Ute Lewitzka, Carlos Lopez- Jaramillo, Glenda MacQueen, Mirko Manchia, Wendy Marsh, M nica Martinez-Cengotitabengoa, Ingrid Melle, Scott Monteith, Gunnar Morken, Rodrigo Munoz , Fabiano G Nery, Claire O'Donovan, Yamima Osher, Andrea Pfennig, Danilo Quiroz, Raj Ramesar, Natalie Rasgon, Andreas Reif, Philipp Ritter, Janusz K Rybakowski, Kemal Sagduyu, gela M Scippa, Emanuel Severus, Christian Simhandl, Dan Stein, Sergio Strejilevich, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagata, Yoshitaka Tatebayashi, Carla Torrent, Eduard Vieta, Biju Viswanath, Mihir J Wanchoo, Mark Zetin, Peter C Whybrow. Influence of light exposure during early life on the age of onset of bipolar disorder. Journal of Psychiatric Research.Volume: 64 Pages: 1-8. May 2015 (ISI-Indexed)
  • Chong Guan Ng, Salina Mohamed, Mee Hoong See, Faizah Harun, Maznah Dahlui, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Nur Aishah Taib. Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: a 1-year prospective study. Health and Quality of Life Outcomes 12/2015; 13(1):205. DOI:10.1186/s12955-015-0401-7. (ISI-Indexed)
  • Srisurapanont M, Likhitsathian S, Chua HC, Udomratn P, Chang S, Maneeton N, Maneeton B, Chen CH, Chan ESY, Bautista D, Sulaiman AHB. Clinical and sociodemographic correlates of severe insomnia in psychotropic drug- free, Asian outpatients with major depressive disorder.Journal of Affective Disorders. Volume: 186 Pages: 26-31. Nov 2015. (ISI-Indexed)
  • Park S, Sulaiman AH, Srisurapanont M, Chang SM, Liu CY, Bautista D, Ge L, Chua HC, Hong, JP The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder.Psychiatry Research Volume: 228 Issue: 3 Pages: 277-282. Aug 2015. (ISI-Indexed)
  • Yee A, Chin SC, Hashim AHB,Singh MKAPH, Loh HS, Sulaiman AH, Ng CG. Anhedonia in depressed patients on treatment with selective serotonin reuptake inhibitor anti-depressant - A two-centered study in Malaysia. International Journal of Psychiatry in Clinical Practice. Volume: 19 Issue: 3 Pages: 182-187 (ISI-Indexed)

2014
  • Ng C.G., Mohamed S., Wern T.Y., Haris A., Zainal N.Z., Sulaiman A.H.2014. Comparison of Psychotropic Prescriptions between Oncology and Cardiology Inpatients: Result from a Pharmacy Database in a Teaching Hospital in Malaysia. Asian Pacific Journal of Cancer Prevention. 15(10):4261 (ISI-Indexed)
  • Schreiner A, Hargarter L, Hitschfield K, Lee JI, Lenskaya I, Sulaiman AH, Diels J. Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR). Current Medical Research and Opinion 30(7):1279-1289. (ISI-Indexed)
  • Siti Norsyuhada Roffeei, Gavin P. Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida & Zahurin Mohamed. 2014. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Hum. Psychopharmacol Clin Exp 29: 38 45 (ISI-Indexed)
  • Ah-Young Lim, Ah-Rong Lee, Ahmad Hatim, Si Tian-Mei, Chia-Yih Liu, Hong Jin Jeon, Pichet Udomratn, Dianne Bautista, Edwin Chan, Shen-ing Liu, Hong Choon Chua, Jin Pyo Hong. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries. BMC Psychiatry 2014, 14:37 (ISI-Indexed)
  • Michael Bauer, Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos,Raffaella Ardau, Christopher Baethge, Rita Bauer, Frank Bellivier,Robert H. Belmaker, Michael Berk, Thomas D. Bjella, Letizia Bossini,Yuly Bersudsky, Eric Yat Wo Cheung, Jörn Conell, Maria Del Zompo, Seetal Doddk,Bruno Etain, Andrea Fagiolini, Mark A. Fryes, Kostas N. Fountoulakis ,Jade Garneau-Fournier, Ana Gonz lez-Pinto, Hirohiko Harima,Stefanie Hassel,Chantal Henry, Apostolos Iacovides, Erkki T. Isomets , Fl vio Kapczinski,Sebastian Kliwicki, Barbara K nig, Rikke Kroghad, Mauricio Kunz, Beny Lafer,Erik R. Larsen, Ute Lewitzk, Carlos Lopez-Jaramillo, Glenda MacQueen,Mirko Manchi, Wendy Marsh, M nica Martinez-Cengotitabengo, Ingrid Melle,Scott Monteith, Gunnar Morken, Rodrigo Munoz, Fabiano G. Nery,Claire O Donovan, Yamima Osher, Andrea Pfennig, Danilo Quiroz, Raj Ramesar,Natalie Rasgon, Andreas Reif, Philipp Ritter, Janusz K.Rybakowski,Kemal Sagduyu, ngela M. Scippaao, Emanuel Severus, Christian Simhandl,Dan J. Steinap, Sergio Strejilevich, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagata, Yoshitaka Tatebayashi, Carla Torrent, Eduard Vieta,Biju Viswanath, Mihir J. Wanchoo, Mark Zetin, Peter C. Whybrow. Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study. Journal of Affective Disorders. 167(2014):104 111 (ISI-Indexed)
  • Siti Norsyuhada Roffeei, Zahurin Mohamed, Gavin P Reynolds, Mas Ayu Said, Ahmad Hatim, Elsa Haniffah Mejia Mohamed, Syarinaz Ahmad Aida, Nor Zuraida Zainal. Association of FTO, LEPR and MTHFR gene polymorohisms with metabolic syndrome in schizophrenia patients receiving antispychotics. Pharmacogenomics (2014). 15 (4): 477-485. (ISI-Indexed)
  • Ng, C. G., Boks, M. P. M., Roes, K. C. B., Zainal, N. Z., Sulaiman, A. H., Tan, S. B., & de Wit, N. J. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four- week, randomized, double-blinded, placebo-controlled study. European Neuropsychopharmacology(0). doi: http://dx.doi.org/10.1016/j.euroneuro.2014.01.016 
  • Ahmad Hatim Sulaiman, Mas Ayu, Mohd Hussain Habil, Rusdi Rashid, Amer Siddiq, Ng Chong Guan, Marhani Midin, Nik Ruzyanei Nik Jaafar, Hatta Sidi, Srijit Das.The Risk and Associated Factors of Methamphetamine Psychosis in Methamphetamine Dependent Patients in Malaysia. Comprehensive Psychiatry. 55 (Jan 2014):S89- S94. (Tier 2; Impact Factor = 2.2) (ISI-Indexed)
  • Sim MS, Hatim A, Diong SH, Mohamed Z. Genetic polymorphism in DTNBP1 gene is associated with methamphetamine-induced panic disorder. J Addict Med. 2014 Nov-Dec;8(6):431-7 (ISI-Indexed)

2013
  • Mas Ayu Said, A Hatim, MH Habil, Wan Zafidah, Haslina MY, Badiah Y, Ramli MA, Ananjit S, Sapini Y, Mohd Shah, Badli Mahmud, Awang Bulgiba, Noran N Hairi. Metabolic syndrome and monotherapy antipsychotic treatment among schizophrenia patients in Malaysia. Preventive Medicine. 2013; 57 ; S50 - S53 (ISI-Indexed)
  • Mohd Fadzli Mohamad Isa, Ng Chong Guan, Rusdi Abd Rashid, Mohd Hussain Habil, Hatta Sidi, Mas Ayu Said, Ahmad Hatim Sulaiman.2013. Sexual Behaviour among Male Methamphetamine and Heroin Dependents in Selected Areas in Malaysia. Sains Malaysiana, 42(12): 1819-1826 (ISI-Indexed)
  • Manit Srisurapanont, Jin Pyo Hong, Si Tian-mei, Ahmad Hatim, Chia-Yih Liu, Pichet Udomratn, Jae Nam Bae, Yiru Fang, Hong Choon Chua, Shen-Ing Liu, Tom George11 MD, Dianne Bautista, Edwin Chan & A. John Rush; For the MD RAN. Clinical features of depression in Asia: Results of a large prospective, cross-sectional study. Asia-Pacific Psychiatry 2013, DOI:10.1111/appy.12104. (ISI-Indexed)
  • M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.PHARMACOGENOMICS 14(5):505-14 · APRIL 2013. Impact Factor: 3.43 · DOI: 10.2217/pgs.13.25 (ISI-Indexed)
  • Ng Chong Guan, Marco PM Boks, Ahmad Hatim Sulaiman, Nor Zuraida Zaina, Niek J De Wit. (2013). Diagnostic Criteria for Major Depressive Disorder in Cancer Patients; a review. International Journal of Psychiatry in Medicine. 45(1): 73-82. (ISI-Indexed)
  • Koh Ong Hui, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Subash Kumar Pillai,Stephen Thevanathan Jambunathan, Rusdi Abdul Rashid. A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia. Bulletin of Clinical Psychopharmacology. 2013;23(1):14-23 (ISI-Indexed)
  • Ahmad H. Sulaiman, Dianne Bautista, Chia-Yih Liu, Pichet Udomratn, Jae Nam Bae, Yiru Fang,Hong C. Chua,Shen-Ing Liu,Tom George, Edwin Chan, Si Tian-mei, Jin Pyo Hong, Manit Srisurapanont,A. John Rush,and the Mood Disorders Research: Asian & Australian Network. Differences in psychiatric symptoms among Asian patients with depression: A multi-country cross- sectional study. Psychiatry and Clinical Neurosciences. (ISI-Indexed)
  • Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu Said, Nor Zuraida Zainal, Mohad Hussain Habil, Ng Chong Guan. Non-Psychotic Psychiatric Co-Morbidities in Patients with Methamphetamine Dependence in Malaysia. International Medical Journal.(Accepted for Publication) (ISI-Indexed)

2012
  • Mas Ayu Said, Ahmad Hatim Sulaiman, Mohd Hussain Habil, Srijit Das, Abdul Kadir Abu Bakar, Rosliwati Md. Yusoff, Loo Tsui Huei, Shamshunnisah Abu Bakar. Metabolic syndrome and cardiovascular risk among schizophrenia patients receiving antipsychotics in Malaysia. Singapore Medical Journal,2012;53(12):801-807 (ISI-Indexed)
  • Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu said, Mohamad Hussain habil, Nor Zuraida Zainal, Chong Guan Ng. 2012. An open label study of aripiprazole for methamphetamine induce psychosis. Bulletin of Clinical Psychopharmacology.2012;22(2):121-9 (ISI-Indexed)
  • Eduard Vietaa, Stuart Montgomery, Ahmad Hatim Sulaiman, Rodrigo Cordoba, Benedicte Huberlant, Lupe Martinez, Andreas Schreiner. 2012. A randomized,double- blind,placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable inpatients with bipolar I disorder. European Neuropsychopharmacology(2012 Nov) 22 (11), 825�835 (ISI-Indexed)
  • Coppola D, Liu Y, Gopal S, Remmerie B, Samtani MN, Hough DW, Nuamah I, Sulaiman A, Pandina G. 2012. A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia. BMC Psychiatry,2012 Mar 28;12(1):26. (Tier 2; Impact Factor = 2.5) (ISI-Indexed)
  • Sulaiman AH, Gill JS, Said MA, Zainal NZ, Hussein HM, Guan NC.2012. A Randomized, Placebo- Controlled Trial of Aripiprazole For The Treatment Of Methamphetamine Dependence and Associated Psychosis. International Journal of Psychiatry in Clinical Practice, 2012;Early Online: 1-8. doi:10.3109/13651501.2012.667116. (ISI-Indexed)
  • Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. Substance use, sexual intercourse, and condom non-use among depressed adolescents and young adults: scientific views.Journal of Adolescent Health, 2012;50:654-655. (ISI-Indexed)
  • Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. An insight on career satisfaction level, mental distress, and gender differences in working conditions among Japanese Obstetricians and Gynecologists. The Journal of Obstetrics and Gynaecology Research, 2012. doi:10.1111/j.1447-0756.2012.01966.x (Early online publication) (ISI-Indexed)

2011
  • A. Hatim, S. Mas Ayu, H. Habil, M. Mustafa, J. Gill, R. Rusdi and A. Amer Siddiq. Psychiatric co-morbidity and suicidality among methamphetamine dependent patients who seek treatment in Malaysia. European Neuropsyhopharmacology, 2011,21(2): S161 (ISI-Indexed)

2010
  • Noor Zurani Md Haris Robson, Stephen Jambunathan, Jesjeet S Gill, Ahmad Hatim Sulaiman, Mohammad Hussain Habil. Research, casuistry and psychiatry An Asian perspective. Asean Journal of Psychiatry, Vol.11(1): Jan June 2010: 2-5 (Non-ISI/Non-SCOPUS)
  • Rusdi Abd. Rashid, Noor Zurani Md Haris Robson, Ahmad Hatim Sulaiman, Rabaiah Salleh, Nor Zuraida Zainal, Mas Ayu Said, Mohammad Hussain Habil. Schizophrenia, Substance use and aggressions: What are the relationships? Online Journal ASEAN Journal of Psychiatry. Vol. 11(1): Jan-June 2010. (Non-ISI/Non-SCOPUS)
  • Maw Shin Sim,Zahurin Mohamed,Ahmad Hatim,Vijaya Lejchimi Rajagopal,Mohamad Hussain Habil.2010. Association of brain-derived neurotrophic factor (Val66Met)genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Research (1357):91-96 (ISI-Indexed)
  • Mas Ayu S, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, Sam IC. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. American Journal of Tropical Medicine and Hygiene 2010; 83(6):1245-1248. (ISI-Indexed)

2009
  • Ahmad Hatim. Is the patient really the same after a major depressive episode? Medicographia. April 2009: Volume 31(2): 9 ¿ 10 (Non-ISI/Non-SCOPUS)
  • David M. Clarke, Ahmad Hatim, Brian Ho, Jiyang Pan, Chee Ng, Kang-Seob Oh, Wu Wenyuan, Mak Ki-Yan. Somatic Symptoms of Depression and Anxiety in the Western Pacific Region: Questions and Answers. CNS Spectr. 2009;14(4):1-8 (ISI-Indexed)
  • A Hatim, J Tan,Mas Ayu, H Habil. Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotics agents.Malaysian Journal of Psychiatry. 2.4.2009:1-13 (Non-ISI/Non-SCOPUS)
  • Q.Q. Ang, Y.K. Wing, Y. He, A.H. Sulaiman, N.Y. Chiu, Y.C Shen, C. Zhang, K.H. Lee, P. Singh, R.E. Granger,J. Raskin, M. Dossenbach. 2009. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.The International Journal of Clinical Practice 63 (7):1041-1049. (Tier 1; Impact Factor = 2.4) (ISI-Indexed)

2008
  • Sharmilla T, Ahmad Hatim S, Jambunathan ST. Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine in UMMC Kuala Lumpur. Malaysian Journal of Psychiatry. December 2008: 17(2): 37 ¿ 46 (Non-ISI/Non-SCOPUS)
  • Ahmad Hatim S. Amphetamine type stimulant psychosis: a rising problems in Malaysia. Malaysian Journal of Psychiatry. December 2008: 17(2): 3- 6 (Non-ISI/Non-SCOPUS)
  • A Hatim, JS Gill, TH Yen, M Ariff, OM Lemming, MZ Azhar. Escitalopram in the Treatment of Malaysian Patients with Obsessive-compulsive Disorder. Hong Kong Journal of Psychiatry. December 2008: Volume 18 (4): 152 157 (SCOPUS-Indexed)

2007
  • Zuraida NZ, Ahmad HS. Religiosity and suicide ideation in clinically depressed patients. The Malaysian Journal of Psychiatry, March 2007: 16: 12-15 (Non-ISI/Non-SCOPUS)
  • Jesjeet Singh Gill, Ahmad Hatim Sulaiman, Mohd Hussain Habil. The first methadone programme in Malaysia:overcoming obstacles and achieving the impossible. Asean Journal of Psychiatry., December 2007: Volume 8, 64-70 (Non-ISI/Non-SCOPUS)

2006
  • Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (Non-ISI/Non-SCOPUS)
  • Pillai SK, Ahmad HS, Jesjeet SG, Jambunathan ST. Psychiatric posting in final year medical students: do attitudes change? The Malaysian Journal of Psychiatry, September 2006: 15:26-31. (Non-ISI/Non-SCOPUS)
  • Hatim A, Habil H, Jesjeet SG, Low CC, Joseph J, Jambunathan ST, Zuraida NZ. Safety and efficacy of rapid dose administration of quetiapine in the treatment of bipolar mania. Human Psychopharmacology: Clinical and Experimental, July 2006: Volume 21, 313-318. (ISI-Indexed)
  • Sharmilla K, Ahmad HS. A comparison of insight in schizophrenia, bipolar affective disorder with psychosis and major depression with psychosis. The Malaysian Journal of Psychiatry, March 2006: 14: 35-40 (Non-ISI/Non-SCOPUS)
  • Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (SCOPUS-Indexed)

2004
  • Hang TJ, Hatim A. Insight among patients with schizophrenia in Hospital Permai. The Malaysian Journal of Psychiatry, March 2004: 12: 32-37 (Non-ISI/Non-SCOPUS)

2002
  • Mas A, Hatim A.Stigma in Mental Illness: Attitudes of Medical Students Towards Mental Illness, 2002, Med. J. Malaysia, Vol. 57, no. 4, pg. 427-438 (ISI/SCOPUS Indexed Publication)
  • Hatim A, Zuraida A, Tan KS, Tan CT. Prevalence and Associations of Post Stroke Depression. Neurological Journal of South East Asia, December 2002: 7: 71-75. (ISI-Indexed)

2001
  • Hatim A, Yen TH. The Efficacy and Outcome of Clozapine Usage in Treatment Resistant Schizophrenic Patient in University Malaya Medical Centre. The Malaysian Journal of Psychiatry, September 2001: 9(2): 6-9. (Non-ISI/Non-SCOPUS)
  • Hatim A, Hussain H. General Practitioners¿ View About Treating Schizophrenic Patients in General Practice Settings. The Malaysian Journal of Psychiatry, March 2001: 9(1): 43-47. (Non-ISI/Non-SCOPUS)
Proceeding

2011
  • Sim, Maw Shin; Sulaiman, Ahmad Hatim; Jaafar, Ahmad Nur Fayyadh Ahmad; et al. 2011. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews Volume: 43 Pages: 69-70. (ISI-Indexed)
  • M. Said, A.H. Sulaiman, M.H. Habil. 2011. Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results. European Psychiatry. Volume 26, Suppl 1. page (ISI-Indexed)

2010
  • Said, M. A.; Sulaiman, A. H.; Habil, M. H. Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results. European Psychiatry Volume: 25, page (ISI-Indexed)
  • Thavichachart, N.; Conde, B.; Sobrevega, E.; et al. Efficacy and tolerability study of flexibly dosed paliperidone ER in ASEAN schizophrenia patient who previously unsuccessfully treated with other oral antipsychotics . International Journal of Neuropsychopharmacology Volume: 13 Pages: 243 (ISI-Indexed)

2009
  • Hatim A, Ayu M, Habil H. Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia. European Neuropsychopharmacology Volume: 19 Pages: S654-S655 (ISI-Indexed)
  • Hatim A, Ayu M, Mustafa M, Habil H. Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results. The World Journal of Biological Psychiatry. 2009; 10 (supp 1): 403 (ISI-Indexed)

2008
  • 282-283Said, MA; Sulaiman, AH; Yen, T; et al. Subgroup analysis of Malaysian patients in a randomised, placebo-controlled relapse-prevention study with escitalopram in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology Volume: 11 Pages: 282-283 (ISI-Indexed)
  • A. Hatim, M Ayu, H Habil, JT Tan. Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents. International Journal of Neuropsychopharmacology Volume: 11 Pages: 158-159 (ISI-Indexed)

2007
  • Ahmad Hatim. Psychiatric posting in final year medical students: do attitudes change? World Psychiatric Association Regional Meeting. Seoul, Korea. April 18 ¿ 21, 2007. (Non-ISI/Non-SCOPUS)

2005
  • Ahmad Hatim, Hussain Habil, Mas Ayu. The use of buprenorphine in the treatment of opiate dependence in Malaysia. XIII World Congress of Psychiatry. Cairo, Egypt. 10-15 September 2005 (Non-ISI/Non-SCOPUS)

2004
  • Gill JS, Jambunathan ST, Low CC, Jacob J, Hatim A. Implementing an Early intervention programme that caters to the need of the multicultural population in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):29 (ISI-Indexed)
  • Said, MA; Sulaiman, AH; Gill, JS. 2004. Diabetes mellitus, obesity and lipid abnormalities in schizophrenic patients treated with atypical antipsychotics. International Journal of Neuropsychopharmacology Volume: 7 Pages: S255. (ISI-Indexed)
  • Gill JS, Koh OH, Hatim A, Jambunathan ST. First episode psychosis: cultural differences in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):81 (ISI-Indexed)

2002
  • M Ayu, A Hatim, S Norriah. Risk Factors of Major Depression Among the Post Stroke Patients: A Hospital Based Case-Control Study At University Malaya Medical Centre. The 34th Asia Pacific Academic Consortium for Public Health Conference. Kuala Lumpur, Malaysia. 17- 20 July 2002: page 22 (Non-ISI/Non-SCOPUS)
  • A Hatim, A Mas. Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient. XII World Congress of Psychiatry. Yokohama, Japan. 24 ¿ 29 August 2002: volume 2: 169 (Non-ISI/Non-SCOPUS)

2001
  • A Hatim, N Zuraida, KS Tan, CT Tan. Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur. 4th Biennial Convention of The ASEAN Neurological Association. Kuala Lumpur, Malaysia. 22- 24 March 2001: page 94. (Non-ISI/Non-SCOPUS)
  • A Hatim, N Zuraida. Prevalence and Clinical Determinants of Post Stroke Depression.7th World Congress of Biological Psychiatry. Berlin, Germany. 1- 6 July 2001. (Non-ISI/Non-SCOPUS)
Mass Media(Newspaper,Radio,Tv,Popular Magazine)

2011
  • TV9. Nasi Lemak Kopi O. Masalah penderaan kanak-kanak. 20th February 2011. 

2010
  • Kesedaran perlu ada untuk berubah. I Luv Islam. 31 Disember 2010. Mukasurat 8. 
  • Ajar seks bermula di rumah. I Luv Islam. 22 Oktober 2010. mukasurat 10. 
  • Kesan penagihan methamphetamine. China Press. 2010 

2009
  • Don¿t let anxiety ruin your life. New Straits Times. Life and Times; 20th January 2009: page 8-9. 
  • Penagih dadah sintetik sering hilang pertimbangan. Berita Minggu. 6th September 2009. page 3. 
  • TV3. Malaysia Hari Ini. Anger Management. 16th January 2009 

2007
  • TV9. Rancangan Keluarga di 9: Penyakit Bipolar. 24th December 2007. 
  • RTM: TV2. Social Phobia. 17th July 2007 

2006
  • Nescafe Kickstart ¿Dream Job¿. 22nd January 2006. 
  • TV2 (National Television). Antisocial personality disorder. 16th March 2006 
  • Gila Meroyan (Post-partum Psychosis). Berita Minggu. 7th May 2006 
  • TV3 (Wanita Hari Ini). Kemurungan (Depression). 13th June 2006. 

2005
  • SAKA, sekadar gangguan mental. Berita Harian . 1 Mei 2005. page 22 
  • Mangsa Tsunami perlu diberikan sokongan moral. Ruangan Wawancara. Mingguan Malaysia. 2 Januari 2005, mukasurat 7 

2004
  • Rancangan: Cegah Dan Rawat. April 19, 2004 
  • Mimpi ngeri misteri ganguan tidur. Ruangan Kesihatan, Mingguan Malaysia. 7 November 2004. Mukasurat 25. 
  • Hit by hysteria. Sunday Mail May 23, 2004 
  • Unsur ganas galak tingkah laku agresif. Mingguan Malaysia. Mei 23, 2004 
  • Rawatan selamat kikis ketagihan dadah. Berita Harian. April 8, 2004. 
  • Treating addiction as a medical condition. Health Today Magazine. April 2004: page 39. 
  • New hope for addicts. New Straits Times. March 31, 2004: page 9 

2003
  • Masyarakat masih kurang kesedaran penyakit skizophrenia. Berita Harian. September 12, 2003: page C13. 
  • Psychiatrist¿s sofa is not all that bad. The New Sunday Times. Jan 19, 2003: page F4 

2002
  • Befriending the depressed. The New Sunday Times. June 16, 2002: page F4 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).

  • A Double-blind, Randomized, Active -controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation, Principal Investigator(PI), 2018 - 2021, International Funding, (International)
  • A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide", Principal Investigator(PI), 2017 - 2019, Private Funding, (International)
  • An Open-label Long-Term Extension Safety Study of Intranasal Esketamine in Treatment-resistant Depression, Principal Investigator(PI), 2017 - 2020, Private Funding, (International)
  • Investigating Technostress In Mobile Im Usage In Managing Work, Consultant, 2017 - 2019, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HNE (Humanities & Ethics), (University)
  • An Open-Label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression., Principal Investigator(PI), 2016 - 2019, International Funding, (International)
  • A 52-week, Open-label, Prospective, Multicenter, International Study of a Transistion to the Paliperidone Palmitate 3-month Formulation in Patients with Schizophenia Previously Stabilized on the Paliperidone Palmitate 1-month Formulation, Principal Investigator(PI), 2016 - 2018, International Funding, (International)
  • Confirmatory Study of DSP-5423P in Patients with Schizophrenia, Principal Investigator(PI), 2015 - 2019, International Funding, (International)
  • A phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administered doses of BI409306 during a 12-week treatment period in patients with schizophrenia on stable antipsychotic treatment., Principal Investigator(PI), 2015 - 2017, International Funding, (International)
  • A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for Treatment of Bipolar I Depression, Principal Investigator(PI), 2015 - 2017, International Funding, (International)
  • A Long Term Study of SM-134963 in Patients with Bipolar I Disorder., Principal Investigator(PI), 2015 - 2017, International Funding, (International)
  • A Multicenter, Randomized, Double-blind Trial to Assess the Efficacy and Safety of ASC-01 in Patients with Major Depressive Disorder, Principal Investigator(PI), 2015 - 2017, International Funding, (International)
  • Alcohol Consumption Among Pregnant Women, Consultant, 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Outcome Of Aripiprozole Versus Repiridone Among Ats Users In Cure & Care Centre, Consultant, 2013 - 2016, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Prevalence Of Amphetamine (ats) Use In Secondary School And Community At Northern Penisular Malaysia, Principal Investigator(PI), 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Identification, Prevention And Intervention: A Review Of Policies - Focused Strategies To Reduce Problematic Alcohol Consumption By College And University Students, Consultant, 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Validation Of The Malay Version Of Amphetamine Withdrawal Questionaire, (aws), Brief Psychiatric Rating Scales (bprs) Madrs, & Mini International Neuropsychiatric Interview (mini 6.0), Consultant, 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • The Effectiveness of Islamic Cognitive Therapy (ICT) and Cognitive Behaviour Therapy (CBT) among Malaysian Addicted Patients, Consultant, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • A phase 3, multicentre, randomized, double blinf, placebo conttrolled study of the efficacy and safety of ALKS 9072 in subjects with acute exacerbation of schizophrenia, Principal Investigator(PI), 2012 - 2014, ALKERMES, INC (United States of America), (International)
  • Major Depressive Disorder among Palliative Patients Comparing 4 sets of Diagnostic Criteria, Consultant, 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients with Schizophrenia, Principal Investigator(PI), 2011 - 2018, Otsuka Pharmaceutical Development (United States of America), (International)
  • Efficacy and safety of escitalopram in diabetic patients with major depression., Principal Investigator(PI), 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase -5 inibitor., Principal Investigator(PI), 2011 - 2012, Janssen Cilag, (International)
  • Randomized controlled trial of the safety and efficacy of aripiprazole versus ziprazidone in schizophrenic patients with metabolic syndrome and diabetes mellitus, Principal Investigator(PI), 2010 - 2012, Pfizer Sdn Bhd, (National)
  • Recognising ethnic differences in depression - a multinational, observational study to detect potential differences in depression in various asian populations., Principal Investigator(PI), 2009 - 2011, Lundbeck (Denmark), (International)
  • The association study of various genetic polymorphisms and drug addiction to stimulants in Malaysian populations, Principal Investigator(PI), 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • An open-label prospective trial to explore tolerability, safety and efficacy of flexible dosed paliperidone ER in subjects with schizophrenia, Principal Investigator(PI), 2008 - 2009, Janssen- Cilag, (International)
  • Seroprevalence survey of Chikungunya virus in Bagan Panchor Malaysia, Co-Investigator, 2008 - 2009, Short Term Research Fund (Vote F)(PJP), (National)
  • A one year prospective study of safety, tolerability and pharmacokinetics of the highest avaialable dose of paliperidone palmitate in patients with schizophrenia, Principal Investigator(PI), 2008 - 2010, Janssen Cilag (United States of America), (International)
  • A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder, Principal Investigator(PI), 2008 - 2009, Janssen Cilag (Europe), (International)
  • Association between genetic polymorhism with drug addiction to stimulants, Principal Investigator(PI), 2007 - 2008, Short Term Research Fund (Vote F)(PJP), (National)
  • Randomised, double-blind, parallel-group, placebo- controlled, duloxetine referenced, dose-finding study of Lu AA24530 in Major Depressive Disorder., Principal Investigator(PI), 2007 - 2009, Lundbeck (Denmark), (International)
  • A phase IIA, randomized, double blind, placebo controlled, 2 period, cross over clinical trail to study the safety and efficacy of MK 0557 for the treatment of cognitive impairment in patients with schizophrenia, Principal Investigator(PI), 2007 - 2009, Merck Sharp and Dohme (MSD) (USA), (International)
  • Depression in a Group of Post Myocardial Infarct Patient, Co-Investigator, 2007 - 2009, Peruntukan Jangkamasa Pendek, (International)
  • Escitalopram in the treatment of Malaysian patients with obsessive compulsive disorder, Principal Investigator(PI), 2006 - 2007, Lundbeck (Denmark), (National)
  • Safety and efficacy of rapid dose administration of quetiapine in bipolar mania, Principal Investigator(PI), 2005 - 2006, Astra Zeneca Pharmaceutical, (National)
  • Risperidone and olanzapine in patient utilization in the University of Malaya Medical Centre, Kuala Lumpur, Principal Investigator(PI), 2005 - 2006, Janssen Cilag, (National)
  • Methadone treatment for herion dependence in Malaysia., Co-Investigator, 2005 - 2006, Duopharma Pharmaceutical, (National)
  • Bipolar Disorder
  • Psychopharmacology
  • Depression
  • Schizophrenia

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).

  • Psychiatry Steering Committee, 2018-2018, Johnson & Johnson Sdn. Bhd
  • Psychiatry Expert Meeting, 2018-2018, A.Menarini
  • Regional Neuroscience Advisory Board, 2018-2018, Janssen Asia Pacific
  • Consultant to Substance Abuse and Research Centre, 2012-2012, Substance Abuse and Research Centre, Jazan University, Saudi Arabia
  • Chairman, Data safety Monitoring Board, 2012-2012, Mitshubishi Tanabe Pharma Corporation
  • Scientific Coordinator, 2012-2012, Institut De Recherches Internationales Servier
  • Consultancy Services, 2012-2012, H. Lundbeck A/S
  • A multicenter, active-controlled double-blind, parallel group comparison trial to investigate the efficacy and safety of aripiprazole intramuscular depot (opc-14597imd) compared with aripiprazole tablet in patients with schizophrenia), 2011-2011, Otsuka Pharmaceutical Japan
  • Kajian R092670-SCH3009 Safety, Tolerability and Treatment Respone of Paliperidone Palmitate In Subjects With Schizophrenia When Switching From Oral Antipsychotics, 2010, Johnson-Johnson Sdn Bhd - Jassen Cilag Div
  • ALBERIO: A multi-national, Multi Center, double blind, placebo-controlled, parallel group. Fixed dose efficacy and safety study of SR58611A 350 mg Twice daily vs. placebo in adults with Major Depressive Disorder on Concomitant Treatment with escitalopram, 2010, Sanofi Aventis Sdn Bhd
  • LTE6673: Efficacy and Safety of 2mg/day of M100907 on sleep maintenance insomnia with a sub study of the effect of M100907 on stable type TT diabetes melitus : A one year, multi centre, randomized, double blind, placebo controlled study, 2010, Sanofi Aventis Sdn Bhd
  • Kajian Couple Study : A Prospective, Randomized, Double Blind, Placebo Controlled, Parallel-Group, Multicentre Study of The Efficacy and Safety of Dapoxetine Inmen with Premature Ejaculation and Concomitant Erectile Dysfunction Treated with a Phosphodiesterase - 2 Inhibitor", 2010, Johnson-Johnson Sdn Bhd - Jassen Cilag Div
  • A prospective, randomized, active controlled, rater blinded study of the prevention of relapse comparing palmitate with oral risperidone in adults with recently diagnosed schizophrenia who are at high risk of relapse., 2009-2009, Janssen Cilag
  • A randomized, double-blind, parallel-group, placebo-controlled, fixed-dose study comparing the efficacy and safety of 3 doses of lu aa21004 in acute major depression., 2009-2009, Takeda
  • A prospective, observational study comparing the frequency of treatment-emergent sexual dysfunction over 8 weeks in patients with major depressive disorder treated with either duloxetine hydrochloride or a selective serotonin reuptake inhibitor antidepressant and evaluated for 6 months, 2009-2009, Eli Lilly Sdn Bhd
  • A 3-weeks, open label study to evaluate the efficacy in agitation and safety of quetiapine fumarate (seroquel xr) in the treatment of patients with acute schizophrenia., 2009-2009, Astra Zeneca Pharmaceutical
  • A one year multi national, multi centre, randomized, double blind, parallel group, fixed dose, bifeprunox study combining a 12 week placebo., 2008-2008, Lundbeck
  • A multicenter, randomized, double-blind, placebo-controlled, parallel grou-comparison trial of aripiprazole in the treatment of patients with bipolar disorder experiencing a manic or mixed episode, 2008-2008, Otsuka Pharmaceutical Japan
  • Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILLAR), 2008-2008, Janssen Cilag
  • A single dose, open-label, randomized, parallel group safety to assess the pharmacokinetic, safety and tolerability of a paliperidone palmitate 3 monthly formulation., 2008-2008, Janssen Cilag
  • A phase 3 randomized, placebo-controlled, clinikal trial to study the safety and efficacy of three doses of lurasidone hcl in acutely psychotic patients with schizophrenia., 2008-2008, Danippon Sumitomo
  • A randomized,double blind,placebo controlled,parallel group study to evaluate the efficacy and safety of flexible dose paliperidone ER in the treatment of subject with schizoaffective., 2007-2007, Quintiles East Asia
  • A randomized double-blind, placebo controlled, parallel-group dose response study to evaluate the efficacy and safety of 3 fixed doses of paliperidone palmitate in subjects with schizophrenia, 2007-2007, Janssen Cilag
  • Efficacy and safety of 2mg/ day of M100907 on sleep maintenance insomnia with a sub study of the effect of M100907 on stable type ii diabetes mellitus : a one year, multi centre, randomized, double blind, placebo controlled study., 2007-2007, Sanofi Aventis
  • Coordinating Investigator, 2007-2007, Lundbeck A/S
  • A multi-national, multi-center, double-blind, placebo-controlled, parallel group, fixed dose efficacy and safety study of SR58611a 350 mg twice daily vs placebo in adult with major depression., 2007-2007, Sanofi Aventis
  • A double-blind, randomized, parallel-group, placebo controlled study of the safety, tolerability and efficacy following sequential dose regimens of Lu 31-130 in male schizophrenia., 2007-2007, Lundbeck
  • Safety, tolerability and treatment response of paliperidone palmitate in subjects with schizophrenia when switching from oral antipsychotics., 2006-2006, Janssen Cilag
  • Scientific National Coordinator, 2006-2006, Institut De Recherches Internationales Servier (IRIS)
  • Advisory Board Member, 2006-2006, Wyeth Pharmaceutical Inc
  • A six week, double blind, placebo-controlled phase iii trial evaluating the efficacy, safety and pharmacokinetics of flexible doses of oral ziprazidone in adolescent subject with schizophrenia., 2006-2006, Pfizer

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).

  • Best Lecturer Award for Post Graduate (Psychiatry), Faculty of Medicine, 2017, (Ptj)
  • Excellence Service Award, University Malaya, 2013, (University)
  • Pengarang Buku Terlaris 2007, Penerbitan Universiti Malaya, 2008, (University)
  • Certificate of Excellent Service, University Malaya, 2006, (University)
  • Excellence Service Award, University Malaya, 2004, (University)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2004, (University)
  • Best Research Paper Competition, Malaysian Psychiatric Association, 2004, (National)
  • Best Psychiatrist Trainee Award, Malaysian Psychiatric Association, 2001, (National)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).

PLEANARY/KEYNOTE SPEAKER
  • Addiction Psychiatry, 12th Johor Mental Health Convention, 2010-05-31 to 2010-06-02, Hospital Permai Johor Bharu, (National)
  • Atypical antipsychotics in mood disorders, 13th Johor Mental Health Conference, 2011-05-20 to 2011-05-21, Hospital Permai Johor, (National)
  • Managing bipolar disorder from acute to maintenance: focusing on patient outcomes, Symposium: Galvanizing the exploration of mental health conundrums of the young, adults and the elderly, 2011-10-14 to 2011-10-15, Pertubuhan Pendidikkan Psikiatri Taiping, (National)
  • Unmet needs of Bipolar and Schizophrenia, Unveiling the untypical, 2011-10-23 to 2011-10-23, Lundbeck Malaysia, (National)
  • Managing Broad Symptoms of Major Depressive Disorder, 9th Perak Mental Health Convention, 2012-10-09 to 2012-10-10, Hospital Bahagia Ulu Kinta, (National)
  • Early detetction of depression in patients with diabetes mellitus, Diabetes Asia 2013 Conference, 2013-10-24 to 2013-10-27, National Diabetic Institute, (International)
INVITED SPEAKER
  • Safety and efficacy of rapid dose administration of quetiapine in bipolar mania. , ISS Investigators Meeting, 2006-11-29 to 2006-12-01, Astra Zeneca, (International)
  • Psychiatric posting in final year medical students: do attitudes change? , World Psychiatric Association Regional Meeting., 2007-04-18 to 2007-04-21, World Psychiatric Association , (International)
  • Atypical antipsychotic usage in Malaysia. , Collegium International Neuropsychopharmacology (CINP) Regional Conference, 2008-03-02 to 2008-03-05, Collegium International Neuropsychopharmacology , (International)
  • Paradigm shift in treatment goals for Depression and Anxiety , 4th Sabah MEntal Health Conference, 2008-05-22 to 2008-05-24, Hospital Mesra Bukit Padang, (National)
  • Remission in depression, 3rd Sarawak Mental Health Conference, 2009-08-06 to 2009-08-08, Hospital Sentosa Kuching, (National)
  • Management of schizophrenia, Workshop: Management of Psychosis, 2009-10-28 to 2009-10-28, Hospital Sultanah Bahiyah, (National)
  • FDA inspection in Malaysia, US FDA Inspection: Experience Sharing Seminar, 2009-11-24 to 2009-11-24, Quintiles, (International)
  • Methamphetamine psychosis, Seminar: Substance Abuse Perils, 2010-04-25 to 2010-04-25, Malaysian Medical Association, (National)
  • Managing Metabolic Syndrome in Schizophrenia, 12th Congress of ASEAN Federation for Psychiatry and Mental Health, 2010-06-24 to 2010-06-26, ASEAN Federation for Psychiatry and Mental Health, (International)
  • Wellness program, 7th Kuala Lumpur Mental Health Conference , 2010-07-26 to 2010-07-28, Badan Kebajikan Psikiatri Hospital Kuala Lumpur, (National)
  • Metabolic syndrome in schizophrenia, 8th Perak Mental Health Convention, 2010-10-08 to 2010-10-10, Hospital Bahagia Ulu Kinta, (National)
  • The scourge about designer drugs, 6th National Conference on Addiction Medicine, 2010-10-23 to 2010-10-25, Addiction Medicine Association of Malaysia, (National)
  • Recognizing and managing depression in primary care, 4th Perak Health Conference 2011, 2011-05-16 to 2011-05-18, Malaysian Association of Public Health Physicians and Perak State Health Department, (National)
  • How to improve adherence in Bipolar Affective Disorder? Problems and Solutions in Asian Countries, The Bipolar Education Training in Asia Forum 2011, 2011-10-28 to 2011-10-29, Society for Advancement of Bipolar Affective Disorder, (International)
  • Administering and rating the MADRS, Investigators Meeting for Study 13926A , 2012-07-27 to 2012-07-29, Lundbeck, (International)
  • PANSS National Language Trainer, COMPASS Schizophrenia Investigators Meeting, 2012-10-20 to  , Otsuka Pharmaceutical and Bracket Global, (International)
  • Rating Rules for Hamilton Anxiety Scale , Asian Investigators Meeting, 2012-11-15 to 2012-11-16, Servier Pharmaceutical and Quintiles East Asia, (International)
POSTER
  • The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry. , 2005-09-10 to 2005-09-15, World Psychiatry Association, (International)
  • Aripirazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 2011-03-12 to 2011-03-15, European Psychiatry Association, (International)
  • Prevalence of psychiatric co-morbidity and suicidality among methamphetamine dependence patients., 11th European Collegium Neuropsychopharmacology (ECNP) Regional Meeting , 2011-04-14 to 2011-04-16, European Collegium Neuropsychopharmacology (ECNP), (International)
PRESENTER
  • Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur, 4th Biennial Convention of The ASEAN Neurological Association, 2001-04-01 to  
  • Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient, XII World Congress of Psychiatry, 2002-04-01 to  
  • The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry, 2005-04-01 to  
  • Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents., XXVI Collegium International Neuropsychopharmacology (CINP) Congress, 2008-04-01 to  
  • Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia., 22nd European College of Neuropsychopharmacology Congress, 2009-04-01 to  
  • Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results., 9th World Congress of Biological Psychiatry, 2009-04-01 to  
  • Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results., 18th European Congress of Psychiatry, 2010-04-01 to  
  • Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 2011-04-01 to  
  • Identifying and treating depression: Are you at risk? , Syarahan Perdana, 2019-02-20 to 2019-02-20, Jabatan Perubatan Psikologi & Fakulti Perubatan, (University)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).

  • Editorial Board Member, International Journal of Bipolar Disorders, 2018, 24, (International)
  • Guest Editor for special issue entitled "Advances in Psychopharmacological Treatment" (BSP-CDT-2016-HT68), Current Drug Treatment, 2016, 24, (International)
  • Consultant and Lectures, Substance Abuse Research Centre, Jazan University, Saudi Arabia., 2013, 12, (International)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).

  • Ahli Jawatankuasa Penilaian Teknikal Ubat-ubatan Psikiatri, University Malaya Medical Centre, Expert Advisor, 2013-2017, (University)
  • Trainer for PANSS and CGI scales, Bracket Global USA, Consultant, 2012-2012
  • University Malaya Medical Centre Ethics Committee, University Malaya Medical Centre, Committee Member, 2012-2015, (University)
  • Chairman for Specialty (Psychiatry) Sub Committee, National Specialist Register (Malaysia), Chairman, 2012-2014, (National)
  • Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya, Committee Member, 2012-2018, (University)
  • Asia Bapineuzumab Advisory Board, Pfizer, Expert Advisor, 2012-2012, (International)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).

  • Reviewer for Journal of Public Health Policy, Article In Journal ,  (2018 - 2018)
  • International Journal of Environmental Research and Public Health, Article In Journal ,  (2018 - 2018)
  • Lymphocytes subsets and their association with the severity of patients with major depressive disorder. External examiner for University Sains Malaysia, Thesis ,  (2017 - 2017)
  • Externer Examiner for Final MBBS Professional Exam at University Teknologi Mara, Externer Examiner For Final Mbbs Professional Exam ,  (2017 - 2019)
  • A study of social support, adjustment and academic stress among first year students at Syiah Kuala University, Thesis ,  (2013 - 2013)
  • Externer Examiner for Final MBBS professional Exam at Islamic International University, Malaysia, Externer Examiner For Final Mbbs Professional Exam ,  (2013 - 2013)
  • External Examiner for final professional exam MD, University Sains Malaysia, External Examiner For Final Professional Exam Md ,  (2013 - 2013)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).

  • Kursus Bimbingan Program Sarjana Psikiatri 2012, (National), 16/12/2012 until 18/12/2012
  • Ahli Jawatankuasa Penganjur bagi Persidangan "International Society of Addiction Medicine Conference 2013", (International), 01/01/2012 until 30/06/2013
  • Presented Lecture during Bipolar Education Forum In Hong Kong, (International), 28/10/2011 until 30/10/2011
  • Lecture during Taiping Mental Health Conference, (National), 15/10/2011 until 16/10/2011
  • Public Lecture and Facilitator during Schizophrenia Relapse Prevention Forum, (National), 07/10/2011 until 09/10/2011
  • Invited as Panel Speaker in Talk Show "Nasi Lemak Kopi O" TV9, (National), 20/02/2011 until 20/02/2011
  • Lecture on "How to prepare FDA inspection", Fullerton Hotel, Singapore. 24 November 2009., (International), 24/11/2009 until 24/11/2009
  • Lecture on Management of Schizophrenia. Hospital Alor Star. 28 October 2009, (Government), 28/10/2009 until 28/10/2009
  • Lecture on Management of Depression. Hospital Bahagia Ulu Kinta. 30 July 2009., (Government), 30/07/2009 until 30/07/2009
  • Workshop on Treatment Resistant Schizophrenia. Hospital Penang. 12 May 2008, (Government), 12/05/2008 until 12/05/2008
  • Organizing Commitee: CINP Regional Conference 1 - 5 March 2008, KL Convention Centre, (International), 01/03/2008 until 05/03/2008
  • Public Lectures on Depression. Armada Hotel, Petaling Jaya. 15 July 2007, (Community), 15/07/2007 until 15/07/2007
  • Organizing Committee: 12th Malaysian Conference on Psychological Medicine, 24-26 Jun 2007. Park Royal Hotel Kuala Lumpur., (National), 24/06/2007 until 27/06/2007
  • Lecture on Stress Management at International Islamic University Malaysia, (Government), 27/02/2007 until 27/02/2007
  • Train the Trainer Workshop for Bipolar Psychoeducation. Le Meridien hotel, Kuala Lumpur. 4 March 2006, (Private), 04/03/2006 until 04/03/2006
  • Functionality in Schizophrenia Workshop. Hilton Hotel, Petaling Jaya. 22 January 2006., (National), 22/01/2006 until 22/01/2006
  • Schizoprenia Workshop for General Practitioners. 13 November 2005. Hilton Petaling Jaya, (National), 13/11/2005 until 13/11/2005
  • Lectures on Stress Management for Telekom Staff, (Private), 28/09/2005 until 28/09/2005
  • Organizing Committee: 10th Malaysian Conference on Psychological Medicine 24-26 Jun 2004, JW Marriot Hotel, Kuala Lumpur., (National), 24/06/2004 until 26/06/2004

SUPERVISION

POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed
  • Master Degree, Sim Maw Shin, Association between single nucleotide polymorphisms of various candidate genes with methamphetamine dependence in the Malaysian population, 2010/2011
  • Master Degree, Dr Nurul Azreen Bt Hashim, Depression and quality of life in patients with type 2 diabetes mellitus, 2010/2011
  • Master Degree, Dr Mohd Fadzli Mohamad Isa, Sexual behaviour among amphetamine type stimulant users in Malaysian drug rehabilitation centre, 2010/2011
  • Master Degree, Dr Amer Siddiq Amer Nordin, Risk factors for depression after myocardial infarction, 2007/2008
  • Master Degree, Dr Mashitah, Prevalence of depression among patients with ischaemic heart disease, 2006/2007
  • Master Degree, Dr Zuraida Ahmad Sabki, Case Protocol of Panic Disorder with Agaraophobia, 2006/2007
  • Master Degree, Dr Aminuddin, Risk factors of relapse among heroin addicts, 2006/2007
  • Master Degree, Dr Rusdi Abd Rashid, Prevalence of depression and anxiety among heroin dependence, 2005/2006
  • Master Degree, Dr John Tan Jin Teong, Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotic agent, 2004/2005
  • Master Degree, Dr Khoo Yee Laim, Case Protocol for Psychotherapy, 2004/2005
  • Master Degree, Dr. Ting Joe Hang, Insight among patients with schizophrenia in Hospital Permai, 2003/2004
  • Master Degree, Dr. Chin Loi Fei, Prescribing pattern of antidepressant and antipsychotic, 2003/2004
  • Master Degree, Dr Sharmilla Kanagasundram, Insight among patients with schizophrenia, bipolar and depression, 2002/2003
  • Master Degree, Dr Subash Kumar Pillai, Psychiatric posting in final year medical students: do attitudes change?, 2002/2003
  • Master Degree, Dr Mas Ayu Said, Risk factor for post-stroke depression, 2001/2002
  • Master Degree, Dr. Parameswaran, Marital Therapy Case Protocol, 2001/2002

Ongoing
  • Master Degree, Dr Chin Soo Cheng, The level and associated factors of anhedonia in patients with depression at the outpatient clinic of UMMC, 2012/2013
  • Master Degree, Tan Huey Jing, EFFICACY OF AN EDUCATIONAL MODULE IN ENHANCING AWARENESS AND KNOWLEDGE ON SUBSTANCE ABUSE AMONGST SECONDARY SCHOOL CHILDREN, 2012/2013
  • Master Degree, Dr Aisah Abdul Rahim, The safety and efficacy of escitalopram in the treatment of major depression among diabetis mellitus patients., 2011/2012
FIRST DEGREE/DIPLOMA/PRE-DEGREE
(Course Title), (Academic Session), (No. of Candidates)

Completed
  • Patterns of antipsychotic use among hospitalized schizophrenic patients in UMMC / Bachelor of Pharmacy, 2006/2007, 1
  • Body image concern among female university students / MBBS, 2005/2006, 1
  • Prevalence attitude and practice towards cigarette smoking among medical doctors in UMMC / MBBS, 2005/2006, 1
  • Prevalence of Anxiety and depression among medical students / MBBS, 2003/2004, 4
  • Attitudes of paramedic towards patients with mental illness / MBBS, 2002/2003, 1

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).

POST GRADUATE
  • RESEARCH PROJECT PAPER, PART 2, 2016/2017(1,2), 10, 50
  • MNGC6111, 2016/2017(1,2), 30, 70
  • MNGC6246, 2016/2017(1,2), 30, 70
  • MNGC6111, 2015/2016(1,2), 30, 70
  • RESEARCH PROJECT PAPER, PART 2, 2015/2016(1,2), 10, 50
  • MNGC6246, 2015/2016, 30, 70
  • Master in Psychological Medicine, 2011/2012(1,2), 38, 500
  • Master in Psychological Medicine, 2010/2011(1,2), 35, 500
  • Master In Psychological Medicine, 2009/2010(1,2), 34, 500
  • Master In Psychological Medicine, 2008/2009(1,2), 32, 500
FIRST DEGREE
  • CLINICAL ASSESSMENT, 2016/2017(1,2), 150, 90
  • ATTITUDE EVALUATION, 2016/2017(1,2), 150, 30
  • EVALUATION/SUBMISSION, 2016/2017(1,2), 150, 30
  • WRITTEN ASSESSMENT, 2016/2017(1,2), 150, 20
  • WRITTEN ASSESSMENT, 2015/2016(1,2), 150, 20
  • CLINICAL ASSESSMENT, 2015/2016(1,2), 150, 90
  • , 2015/2016(1,2), 150, 30
  • Phase 3B Psychiatry Posting, 2011/2012(1,2), 200, 336
  • Phase 3B Psychiatry Posting, 2010/2011(1,2), 200, 336
  • Phase 3B Psychiatry Posting, 2009/2010(1,2), 200, 336
  • Phase 3B Psychiatry Posting, 2008/2009(1,2), 200, 336